Vitalhub Corp. (TSE:VHI) Receives Consensus Rating of “Buy” from Brokerages

Vitalhub Corp. (TSE:VHI) has been given a consensus rating of “Buy” by the five analysts that are covering the firm, Marketbeat reports. Five analysts have rated the stock with a buy rating. The average 12 month price target among brokerages that have covered the stock in the last year is C$12.08.

Several brokerages recently weighed in on VHI. Raymond James set a C$13.50 price target on shares of Vitalhub and gave the company an “outperform” rating in a research report on Thursday, March 27th. Canaccord Genuity Group raised their target price on Vitalhub from C$12.00 to C$12.50 and gave the stock a “buy” rating in a report on Thursday, January 16th. TD Securities increased their price target on Vitalhub from C$13.00 to C$14.00 and gave the stock a “buy” rating in a research note on Monday. Finally, Scotiabank set a C$14.00 price objective on Vitalhub and gave the company an “outperform” rating in a research report on Thursday, January 30th.

Vitalhub Stock Down 0.9 %

VHI stock opened at C$10.15 on Thursday. Vitalhub has a twelve month low of C$5.80 and a twelve month high of C$12.09. The business has a 50 day moving average of C$10.46 and a 200 day moving average of C$10.36. The firm has a market cap of C$549.04 million, a PE ratio of 165.09, a price-to-earnings-growth ratio of 1.18 and a beta of 1.26.

Vitalhub Company Profile

Vitalhub Corp., together with its subsidiaries, provides technology solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally. Its solutions include electronic healthcare record, case management, care coordination and optimization, and patient flow, engagement, and operational visibility solutions.